Institute of Medicine report calls for extensive overhaul of drug safety procedures at FDA, CDER

被引：0

|

作者：

不详

机构：

来源：

FORMULARY | 2006年 / 41卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：607 / +

页数：3

相关论文

共 30 条

[21] Patient Safety Education 20 Years After the Institute of Medicine Report: Results From a Cross-sectional National Survey
Arora, Sonal
Tsang, Fiona
Kekecs, Zoltan
Shah, Nisha
Archer, Stephanie
Smith, Jason
Darzi, Ara
JOURNAL OF PATIENT SAFETY, 2021, 17 (08) : E1884 - E1888
[22] "Resident Duty Hours: Enhancing Sleep, Supervision, and Safety": Response of the Association of Program Directors in Surgery to the December 2008 Report of the Institute of Medicine
Borman, Karen R.
Fuhrman, George M.
SURGERY, 2009, 146 (03) : 420 - 427
[23] Research on efficacy, toxicity, long-term safety of antiprogestins--including controversial RU-486--is recommended in an institute of medicine report
Chemical & Engineering News, 1993, 71 (37)
[24] Safety in Treatment of Ventilator-Associated Pneumonia Due To Extensive Drug-Resistant Acinetobacter Baumannii With Aerosolized Colistin in Neonates: A Preliminary Report
Nakwan, Narongsak
Wannaro, Jeerawan
Thongmak, Tipaporn
Pornladnum, Pornpat
Saksawad, Ratchanee
Nakwan, Narongwit
Chokephaibulkit, Kulkanya
PEDIATRIC PULMONOLOGY, 2011, 46 (01) : 60 - 66
[25] HIGHLIGHTS OF THE EXECUTIVE SUMMARY OF THE 1991 REPORT BY THE COMMITTEE ON EVALUATION OF THE SAFETY OF FISHERY PRODUCTS OF THE FOOD AND NUTRITION BOARD, INSTITUTE OF MEDICINE, NATIONAL-ACADEMY-OF-SCIENCES
不详
NUTRITION REVIEWS, 1991, 49 (12) : 357 - 363
[26] Tobacco Company Efforts to Influence the Food and Drug Administration-Commissioned Institute of Medicine Report Clearing the Smoke: An Analysis of Documents Released through Litigation
Tan, Crystal E.
Kyriss, Thomas
Glantz, Stanton A.
PLOS MEDICINE, 2013, 10 (05)
[27] Impact of Long-Term Safety Data and FDA Warnings on Drug-Eluting Stent Use in Clinical Practice: A Report from the ACC/National Cardiovascular Data Registry
Krono, Ronald J.
Rao, Sunil V.
Dai, David
Paterson, Eric D.
Shaw, Richard E.
Klein, Lloyd W.
Anderson, H. V.
Weintraub, William S.
Brindis, Ralph G.
CIRCULATION, 2008, 118 (18) : S897 - S897
[28] Expanding Public-Private Collaborations to Enhance Cancer Drug Development: A Report of the Institute of Medicine's Workshop Series, "Implementing a National Cancer Clinical Trials System for the 21st Century"
Bertagnolli, Monica M.
Canetta, Renzo
Nass, Sharyl J.
ONCOLOGIST, 2014, 19 (11): : 1179 - 1185
[29] Resident duty hours in surgery for ensuring patient safety, providing optimum resident education and training, and promoting resident well-being: A response from the American College of Surgeons to the Report of the Institute of Medicine, "Resident Duty Hours: Enhancing Sleep, Supervision, and Safety"
Britt, L. D.
Sachdeva, Ajit K.
Healy, Gerald B.
Whalen, Thomas V.
Blair, Patrice Gabler
SURGERY, 2009, 146 (03) : 398 - 409
[30] Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Ivy, S. Percy
Siu, Lillian L.
Garrett-Mayer, Elizabeth
Rubinstein, Larry
CLINICAL CANCER RESEARCH, 2010, 16 (06) : 1726 - 1736